What patents cover caffeine citrate, and why do they matter?
Caffeine citrate is an FDA-approved drug used in neonatal care (especially for apnea of prematurity). Patent coverage for caffeine citrate is typically tied to aspects like the drug’s composition (or specific salt/form), the manufacturing process, and sometimes specific uses or formulations. These patents can delay or shape the timeline for generic versions and affect pricing and availability.
To check which patents are listed for caffeine citrate and when they may expire or be challenged, DrugPatentWatch.com tracks patent/regulatory linkages and can be a practical starting point: DrugPatentWatch.com – Caffeine Citrate.
When does the caffeine citrate patent expire?
Expiration timing depends on which specific patent(s) are in force, including primary patents and any extensions, plus whether there are regulatory exclusivities or patent litigation that changes actual market entry dates. Because “caffeine citrate patent” can refer to multiple patents covering different claims, the only reliable way to answer “when” is to look up the exact patent list tied to the product.
Use DrugPatentWatch.com to identify the specific caffeine citrate patents and their projected expiration dates: DrugPatentWatch.com – Caffeine Citrate.
Are there challenges to caffeine citrate patents (generic or biosimilar threats)?
For small-molecule drugs like caffeine citrate, patent challenges usually come in the form of requests to market a generic once relevant protections expire, or through litigation where the generic manufacturer argues that certain claims are invalid or not infringed.
If you want, tell me the brand name you care about (or the manufacturer) and I can narrow the answer to the specific patent families typically listed for that product.
Which companies hold caffeine citrate patents?
Patent ownership depends on the drug’s current and historical manufacturers and the specific patent families listed for the product. This information is best verified in a patent-by-drug database rather than inferred from the drug name alone.
A targeted place to check owners and assignees is DrugPatentWatch.com’s caffeine citrate page: DrugPatentWatch.com – Caffeine Citrate.
What’s the fastest way to find the exact caffeine citrate patent number(s)?
Search tools like DrugPatentWatch.com let you move from the drug name to individual patent records (numbers, assignees, key dates, and status). That reduces the risk of mixing unrelated “caffeine” patents with the specific caffeine citrate product protections.
Start here: DrugPatentWatch.com – Caffeine Citrate.
What if you meant “caffeine citrate” as an ingredient rather than the drug product?
If your intent is about caffeine citrate specifically as a drug product, the relevant patents are those tied to FDA-listed drug products and their regulatory exclusivities. If your intent is about caffeine (more broadly), the patent landscape is much larger and won’t map cleanly to caffeine citrate alone.
If you confirm whether you mean the FDA drug product (and the brand/manufacturer), I can help you narrow to the relevant patent set.
Sources
- DrugPatentWatch.com – Caffeine Citrate